 | • レポートコード：MRC2312MG02861 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の植込み型神経調節装置市場規模と予測を収録しています。・世界の植込み型神経調節装置市場：売上、2018年-2023年、2024年-2029年 ・世界の植込み型神経調節装置市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の植込み型神経調節装置市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「脊髄刺激」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 植込み型神経調節装置のグローバル主要企業は、Medtronic、 Abbott、 Boston Scientific Corporation、 St. Jude Medical、 Synapse Biomedical、 Nevro Corporation、 Neuropace、 Cyberonics、 Autonomic Technologies、 Avery Biomedical、 Greatbatch Medicalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、植込み型神経調節装置のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の植込み型神経調節装置市場：タイプ別、2018年-2023年、2024年-2029年 世界の植込み型神経調節装置市場：タイプ別市場シェア、2022年 ・脊髄刺激、脳深部刺激、仙骨神経刺激、迷走神経刺激、胃刺激、その他 世界の植込み型神経調節装置市場：用途別、2018年-2023年、2024年-2029年 世界の植込み型神経調節装置市場：用途別市場シェア、2022年 ・パーキンソン病、てんかん、疼痛、その他 世界の植込み型神経調節装置市場：地域・国別、2018年-2023年、2024年-2029年 世界の植込み型神経調節装置市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における植込み型神経調節装置のグローバル売上、2018年-2023年 ・主要企業における植込み型神経調節装置のグローバル売上シェア、2022年 ・主要企業における植込み型神経調節装置のグローバル販売量、2018年-2023年 ・主要企業における植込み型神経調節装置のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Medtronic、 Abbott、 Boston Scientific Corporation、 St. Jude Medical、 Synapse Biomedical、 Nevro Corporation、 Neuropace、 Cyberonics、 Autonomic Technologies、 Avery Biomedical、 Greatbatch Medical ************************************************************* ・調査・分析レポートの概要 植込み型神経調節装置市場の定義 市場セグメント 世界の植込み型神経調節装置市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の植込み型神経調節装置市場規模 世界の植込み型神経調節装置市場規模：2022年 VS 2029年 世界の植込み型神経調節装置市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの植込み型神経調節装置の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の植込み型神経調節装置製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：脊髄刺激、脳深部刺激、仙骨神経刺激、迷走神経刺激、胃刺激、その他 植込み型神経調節装置のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：パーキンソン病、てんかん、疼痛、その他 植込み型神経調節装置の用途別グローバル売上・予測 ・地域別市場分析 地域別植込み型神経調節装置市場規模 2022年と2029年 地域別植込み型神経調節装置売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Medtronic、 Abbott、 Boston Scientific Corporation、 St. Jude Medical、 Synapse Biomedical、 Nevro Corporation、 Neuropace、 Cyberonics、 Autonomic Technologies、 Avery Biomedical、 Greatbatch Medical ... |
This research report provides a comprehensive analysis of the Implantable Neuromodulation System market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Implantable Neuromodulation System market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Implantable Neuromodulation System, challenges faced by the industry, and potential opportunities for market players.
The global Implantable Neuromodulation System market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Implantable Neuromodulation System market presents opportunities for various stakeholders, including Parkinson’s Disease, Epilepsy. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Implantable Neuromodulation System market. Additionally, the growing consumer demand present avenues for market expansion.
The global Implantable Neuromodulation System market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Implantable Neuromodulation System market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Implantable Neuromodulation System market.
Market Overview: The report provides a comprehensive overview of the Implantable Neuromodulation System market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Spinal Cord Stimulation, Deep Brain Stimulation), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Implantable Neuromodulation System market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Implantable Neuromodulation System market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Implantable Neuromodulation System market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Implantable Neuromodulation System market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Implantable Neuromodulation System market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Implantable Neuromodulation System market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Implantable Neuromodulation System, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Implantable Neuromodulation System market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Implantable Neuromodulation System market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Other
Market segment by Application
Parkinson’s Disease
Epilepsy
Pain
Other
Global Implantable Neuromodulation System Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Medtronic
Abbott
Boston Scientific Corporation
St. Jude Medical
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Implantable Neuromodulation System, market overview.
Chapter 2: Global Implantable Neuromodulation System market size in revenue and volume.
Chapter 3: Detailed analysis of Implantable Neuromodulation System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Implantable Neuromodulation System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Implantable Neuromodulation System capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Implantable Neuromodulation System Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Implantable Neuromodulation System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Implantable Neuromodulation System Overall Market Size
2.1 Global Implantable Neuromodulation System Market Size: 2022 VS 2029
2.2 Global Implantable Neuromodulation System Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Implantable Neuromodulation System Sales: 2018-2029
3 Company Landscape
3.1 Top Implantable Neuromodulation System Players in Global Market
3.2 Top Global Implantable Neuromodulation System Companies Ranked by Revenue
3.3 Global Implantable Neuromodulation System Revenue by Companies
3.4 Global Implantable Neuromodulation System Sales by Companies
3.5 Global Implantable Neuromodulation System Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Implantable Neuromodulation System Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Implantable Neuromodulation System Product Type
3.8 Tier 1, Tier 2 and Tier 3 Implantable Neuromodulation System Players in Global Market
3.8.1 List of Global Tier 1 Implantable Neuromodulation System Companies
3.8.2 List of Global Tier 2 and Tier 3 Implantable Neuromodulation System Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Implantable Neuromodulation System Market Size Markets, 2022 & 2029
4.1.2 Spinal Cord Stimulation
4.1.3 Deep Brain Stimulation
4.1.4 Sacral Nerve Stimulation
4.1.5 Vagal Nerve Stimulation
4.1.6 Gastric Stimulation
4.1.7 Other
4.2 By Type – Global Implantable Neuromodulation System Revenue & Forecasts
4.2.1 By Type – Global Implantable Neuromodulation System Revenue, 2018-2023
4.2.2 By Type – Global Implantable Neuromodulation System Revenue, 2024-2029
4.2.3 By Type – Global Implantable Neuromodulation System Revenue Market Share, 2018-2029
4.3 By Type – Global Implantable Neuromodulation System Sales & Forecasts
4.3.1 By Type – Global Implantable Neuromodulation System Sales, 2018-2023
4.3.2 By Type – Global Implantable Neuromodulation System Sales, 2024-2029
4.3.3 By Type – Global Implantable Neuromodulation System Sales Market Share, 2018-2029
4.4 By Type – Global Implantable Neuromodulation System Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Implantable Neuromodulation System Market Size, 2022 & 2029
5.1.2 Parkinson’s Disease
5.1.3 Epilepsy
5.1.4 Pain
5.1.5 Other
5.2 By Application – Global Implantable Neuromodulation System Revenue & Forecasts
5.2.1 By Application – Global Implantable Neuromodulation System Revenue, 2018-2023
5.2.2 By Application – Global Implantable Neuromodulation System Revenue, 2024-2029
5.2.3 By Application – Global Implantable Neuromodulation System Revenue Market Share, 2018-2029
5.3 By Application – Global Implantable Neuromodulation System Sales & Forecasts
5.3.1 By Application – Global Implantable Neuromodulation System Sales, 2018-2023
5.3.2 By Application – Global Implantable Neuromodulation System Sales, 2024-2029
5.3.3 By Application – Global Implantable Neuromodulation System Sales Market Share, 2018-2029
5.4 By Application – Global Implantable Neuromodulation System Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Implantable Neuromodulation System Market Size, 2022 & 2029
6.2 By Region – Global Implantable Neuromodulation System Revenue & Forecasts
6.2.1 By Region – Global Implantable Neuromodulation System Revenue, 2018-2023
6.2.2 By Region – Global Implantable Neuromodulation System Revenue, 2024-2029
6.2.3 By Region – Global Implantable Neuromodulation System Revenue Market Share, 2018-2029
6.3 By Region – Global Implantable Neuromodulation System Sales & Forecasts
6.3.1 By Region – Global Implantable Neuromodulation System Sales, 2018-2023
6.3.2 By Region – Global Implantable Neuromodulation System Sales, 2024-2029
6.3.3 By Region – Global Implantable Neuromodulation System Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Implantable Neuromodulation System Revenue, 2018-2029
6.4.2 By Country – North America Implantable Neuromodulation System Sales, 2018-2029
6.4.3 US Implantable Neuromodulation System Market Size, 2018-2029
6.4.4 Canada Implantable Neuromodulation System Market Size, 2018-2029
6.4.5 Mexico Implantable Neuromodulation System Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Implantable Neuromodulation System Revenue, 2018-2029
6.5.2 By Country – Europe Implantable Neuromodulation System Sales, 2018-2029
6.5.3 Germany Implantable Neuromodulation System Market Size, 2018-2029
6.5.4 France Implantable Neuromodulation System Market Size, 2018-2029
6.5.5 U.K. Implantable Neuromodulation System Market Size, 2018-2029
6.5.6 Italy Implantable Neuromodulation System Market Size, 2018-2029
6.5.7 Russia Implantable Neuromodulation System Market Size, 2018-2029
6.5.8 Nordic Countries Implantable Neuromodulation System Market Size, 2018-2029
6.5.9 Benelux Implantable Neuromodulation System Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Implantable Neuromodulation System Revenue, 2018-2029
6.6.2 By Region – Asia Implantable Neuromodulation System Sales, 2018-2029
6.6.3 China Implantable Neuromodulation System Market Size, 2018-2029
6.6.4 Japan Implantable Neuromodulation System Market Size, 2018-2029
6.6.5 South Korea Implantable Neuromodulation System Market Size, 2018-2029
6.6.6 Southeast Asia Implantable Neuromodulation System Market Size, 2018-2029
6.6.7 India Implantable Neuromodulation System Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Implantable Neuromodulation System Revenue, 2018-2029
6.7.2 By Country – South America Implantable Neuromodulation System Sales, 2018-2029
6.7.3 Brazil Implantable Neuromodulation System Market Size, 2018-2029
6.7.4 Argentina Implantable Neuromodulation System Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Implantable Neuromodulation System Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Implantable Neuromodulation System Sales, 2018-2029
6.8.3 Turkey Implantable Neuromodulation System Market Size, 2018-2029
6.8.4 Israel Implantable Neuromodulation System Market Size, 2018-2029
6.8.5 Saudi Arabia Implantable Neuromodulation System Market Size, 2018-2029
6.8.6 UAE Implantable Neuromodulation System Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Medtronic
7.1.1 Medtronic Company Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Implantable Neuromodulation System Major Product Offerings
7.1.4 Medtronic Implantable Neuromodulation System Sales and Revenue in Global (2018-2023)
7.1.5 Medtronic Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Implantable Neuromodulation System Major Product Offerings
7.2.4 Abbott Implantable Neuromodulation System Sales and Revenue in Global (2018-2023)
7.2.5 Abbott Key News & Latest Developments
7.3 Boston Scientific Corporation
7.3.1 Boston Scientific Corporation Company Summary
7.3.2 Boston Scientific Corporation Business Overview
7.3.3 Boston Scientific Corporation Implantable Neuromodulation System Major Product Offerings
7.3.4 Boston Scientific Corporation Implantable Neuromodulation System Sales and Revenue in Global (2018-2023)
7.3.5 Boston Scientific Corporation Key News & Latest Developments
7.4 St. Jude Medical
7.4.1 St. Jude Medical Company Summary
7.4.2 St. Jude Medical Business Overview
7.4.3 St. Jude Medical Implantable Neuromodulation System Major Product Offerings
7.4.4 St. Jude Medical Implantable Neuromodulation System Sales and Revenue in Global (2018-2023)
7.4.5 St. Jude Medical Key News & Latest Developments
7.5 Synapse Biomedical
7.5.1 Synapse Biomedical Company Summary
7.5.2 Synapse Biomedical Business Overview
7.5.3 Synapse Biomedical Implantable Neuromodulation System Major Product Offerings
7.5.4 Synapse Biomedical Implantable Neuromodulation System Sales and Revenue in Global (2018-2023)
7.5.5 Synapse Biomedical Key News & Latest Developments
7.6 Nevro Corporation
7.6.1 Nevro Corporation Company Summary
7.6.2 Nevro Corporation Business Overview
7.6.3 Nevro Corporation Implantable Neuromodulation System Major Product Offerings
7.6.4 Nevro Corporation Implantable Neuromodulation System Sales and Revenue in Global (2018-2023)
7.6.5 Nevro Corporation Key News & Latest Developments
7.7 Neuropace
7.7.1 Neuropace Company Summary
7.7.2 Neuropace Business Overview
7.7.3 Neuropace Implantable Neuromodulation System Major Product Offerings
7.7.4 Neuropace Implantable Neuromodulation System Sales and Revenue in Global (2018-2023)
7.7.5 Neuropace Key News & Latest Developments
7.8 Cyberonics
7.8.1 Cyberonics Company Summary
7.8.2 Cyberonics Business Overview
7.8.3 Cyberonics Implantable Neuromodulation System Major Product Offerings
7.8.4 Cyberonics Implantable Neuromodulation System Sales and Revenue in Global (2018-2023)
7.8.5 Cyberonics Key News & Latest Developments
7.9 Autonomic Technologies
7.9.1 Autonomic Technologies Company Summary
7.9.2 Autonomic Technologies Business Overview
7.9.3 Autonomic Technologies Implantable Neuromodulation System Major Product Offerings
7.9.4 Autonomic Technologies Implantable Neuromodulation System Sales and Revenue in Global (2018-2023)
7.9.5 Autonomic Technologies Key News & Latest Developments
7.10 Avery Biomedical
7.10.1 Avery Biomedical Company Summary
7.10.2 Avery Biomedical Business Overview
7.10.3 Avery Biomedical Implantable Neuromodulation System Major Product Offerings
7.10.4 Avery Biomedical Implantable Neuromodulation System Sales and Revenue in Global (2018-2023)
7.10.5 Avery Biomedical Key News & Latest Developments
7.11 Greatbatch Medical
7.11.1 Greatbatch Medical Company Summary
7.11.2 Greatbatch Medical Business Overview
7.11.3 Greatbatch Medical Implantable Neuromodulation System Major Product Offerings
7.11.4 Greatbatch Medical Implantable Neuromodulation System Sales and Revenue in Global (2018-2023)
7.11.5 Greatbatch Medical Key News & Latest Developments
8 Global Implantable Neuromodulation System Production Capacity, Analysis
8.1 Global Implantable Neuromodulation System Production Capacity, 2018-2029
8.2 Implantable Neuromodulation System Production Capacity of Key Manufacturers in Global Market
8.3 Global Implantable Neuromodulation System Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Implantable Neuromodulation System Supply Chain Analysis
10.1 Implantable Neuromodulation System Industry Value Chain
10.2 Implantable Neuromodulation System Upstream Market
10.3 Implantable Neuromodulation System Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Implantable Neuromodulation System Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
